METHODS FOR DETECTING AND SEQUENCING A TARGET NUCLEIC ACID

The present disclosure provides methods for characterizing a target DNA present in a sample. The methods involve contacting the sample with a type V CRISPR/Cas effector protein and one or more guide RNAs, where the contacting generates a cleavage product comprising a 5′ overhang; and ligating a double-stranded nucleic acid adapter to the cleavage product, to generate a ligation product. The ligation product includes the target DNA, which can be sequenced. The sample can be subjected to one or more amplification steps prior to the contacting step, with primers that provide for amplification of nucleic acids of, e.g., specific pathogens, categories of pathogens, two or more different pathogens, or two or more different categories of pathogens..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 10. Aug. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

DOUDNA JENNIFER A [VerfasserIn]
HARRINGTON LUCAS B [VerfasserIn]
CHEN JANICE S [VerfasserIn]
DENG XIANDING [VerfasserIn]
GRANADOS ANDREA [VerfasserIn]
CHIU CHARLES [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
bio
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
C12Q: Measuring or testing processes involving enzymes, n (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-08-10, Last update posted on www.tib.eu: 2023-09-19, Last updated: 2023-09-22

Patentnummer:

EP3884064

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA014449218